Assertio Holdings Inc. (ASRT) Fundamentals

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
SHARE INFORMATION
Market Cap$ 142,206,789
Shares Outstanding45,433,479
Float44,812,885
Percent Float98.63%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 111,012,000
Latest Fiscal EPS$ -0.01
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions110
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months395,722
Institutional Holdings Percent31.1%
Institutional Sold Previous 3 Months170,074
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months351,146
Insider Holdings Percent17.1
Insider Sold Previous 3 Months502,435
Insider Shares Owned7,744,646
TRADING INFO
52 Week High$ 3.52
52 Week Low$ 0.85
52 Week High Change$ 100.64
21 Day Moving Average$ 2.369
21 Day Extended Moving Average$ 2.5716
50 Day Moving Average$ 2.6266
50 Day Extended Moving Average$ 2.538
200 Day Moving Average$ 1.8593
200 Day Extended Moving Average$ 2.2015
10 Day Average Volume1,205,873
20 Day Average Volume922,695
30 Day Average Volume1,017,478
50 Day Average Volume1,011,043
Alpha0.007596
Beta-0.1619
Standard Deviation0.281085
R20.000721
7 Day Price Change$ 0.50
7 Day Percent Change19.01%
21 Day Price Change$ 1.01
21 Day Percent Change47.64%
30 Day Price Change$ 0.36
30 Day Percent Change13.0%
Month to Date Price Change$ 1.02
Month to Date Percent Change48.34%
Quarter to Date Price Change$ 0.26
Quarter to Date Percent Change9.06%
180 Day Price Change$ 1.81
180 Day Percent Change137.12%
200 Day Price Change$ 2.10
200 Day Percent Change203.88%
Year to Date Price Change$ 0.95
Year to Date Percent Change43.58%

Assertio Holdings Inc. (ASRT) Key Ratios

PROFITABILITY
EBIT Margin11.6%
EBITDA Margin37.2%
Pre-Tax Profit Margin-28.0%
Profit Margin Count2.68%
Gross Margin86.8%
Profit Margin TOT2.68%
INCOME STATEMENTS
Revenue$ 120,711,000
Revenue Per Share$ 2.6569
Revenue (3 Years)$ -23.33
Revenue (5 Years)$ -25.90
FINANCIAL STRENGTH
Price to Tangible Book-1.40
Total Debt To Equity0.70
Int Coverage1.40
Current Ratio0.90
Leverage Ratio3.20
Quick Ratio0.80
Long Term Debt To Capital0.35
VALUATION MEASURES
PE Ratio41.90
Enterprise Value$ 145,252,093
Price to Sales1.1781
Price to Free Cash7.30
PE High Last 5 Years13.10
Price To Book1.20
Price To Cash Flow3.60
PE Low Last 5 Years-3.00
Price to Tangible Book-1.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.20
Invoice Turnover1.60
Assets Turnover0.10
Return Assets0.97
Return on Equity2.98
Return on Capital5.85

Assertio Holdings Inc. (ASRT) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorGrant Thornton LLP
CEODaniel A. Peisert
Emplyoees19
Last AuditUQ
CIK0001808665
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address100 South Saunders Road
Suite 300
Lake Forest, IL 60045
Websitehttps://www.assertiotx.com
Facsimile+1 510 744-8001
Telephone+1 224 419-7106
Emaildpeisert@assertiotx.com
Your Recent History
NASDAQ
ASRT
Assertio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220522 23:06:02